Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuval Yaron

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Prenatal Diagnosis|March 5, 2016
The implications of non-invasive prenatal testing failures: a review of an under-discussed phenomenonYuval Yaron
European Journal of Medical Genetics|January 29, 2020
Editorial for the special issueYuval Yaron
Human Reproduction (Oxford, England)|December 30, 2020
Reply: cfDNA testing in recurrent pregnancy loss: a new step in the right way but still raw for the clinical areaYuval Yaron, Antoni Borrell
Clinical Obstetrics and Gynecology|October 9, 2002
New genetic principlesYuval Yaron, Avi Orr-Urtreger
American Journal of Obstetrics and Gynecology|June 15, 2015
Prenatal aneuploidy screening using cell free DNADick Oepkes, Ann Tabor, Yuval Yaron
Prenatal Diagnosis|October 18, 2016
Current controversies in prenatal diagnosis 2: for those women screened by NIPT using cell free DNA, maternal serum markers are obsoleteYuval Yaron, Jon Hyett, Sylvie Langlois
Prenatal Diagnosis|October 20, 2012
Current controversies in prenatal diagnosis 1: screening for fragile X syndromeYuval Yaron, Thomas Musci, Howard Cuckle
Prenatal Diagnosis|May 27, 2022
A founding father of reproductive genetics: Eugene Pergament (1933-2022)Howard Cuckle, Peter Benn, Yuval Yaron
Prenatal Diagnosis|May 28, 2014
Screening for Down syndrome--incidental diagnosis of other aneuploidiesCarla Davis, Howard Cuckle, Yuval Yaron
Fetal Diagnosis and Therapy|February 7, 2004
A comparison between maternal serum free beta-human chorionic gonadotrophin and pregnancy-associated plasma protein A levels in first-trimester twin and singleton pregnanciesRoy Mashiach, Avi Orr-Urtreger, Yuval Yaron
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Prenatal Diagnosis|March 5, 2016
The implications of non-invasive prenatal testing failures: a review of an under-discussed phenomenonYuval Yaron
European Journal of Medical Genetics|January 29, 2020
Editorial for the special issueYuval Yaron
Human Reproduction (Oxford, England)|December 30, 2020
Reply: cfDNA testing in recurrent pregnancy loss: a new step in the right way but still raw for the clinical areaYuval Yaron, Antoni Borrell
Clinical Obstetrics and Gynecology|October 9, 2002
New genetic principlesYuval Yaron, Avi Orr-Urtreger
American Journal of Obstetrics and Gynecology|June 15, 2015
Prenatal aneuploidy screening using cell free DNADick Oepkes, Ann Tabor, Yuval Yaron
Prenatal Diagnosis|October 18, 2016
Current controversies in prenatal diagnosis 2: for those women screened by NIPT using cell free DNA, maternal serum markers are obsoleteYuval Yaron, Jon Hyett, Sylvie Langlois
Prenatal Diagnosis|October 20, 2012
Current controversies in prenatal diagnosis 1: screening for fragile X syndromeYuval Yaron, Thomas Musci, Howard Cuckle
Prenatal Diagnosis|May 27, 2022
A founding father of reproductive genetics: Eugene Pergament (1933-2022)Howard Cuckle, Peter Benn, Yuval Yaron
Prenatal Diagnosis|May 28, 2014
Screening for Down syndrome--incidental diagnosis of other aneuploidiesCarla Davis, Howard Cuckle, Yuval Yaron
Fetal Diagnosis and Therapy|February 7, 2004
A comparison between maternal serum free beta-human chorionic gonadotrophin and pregnancy-associated plasma protein A levels in first-trimester twin and singleton pregnanciesRoy Mashiach, Avi Orr-Urtreger, Yuval Yaron
Pageof 13